Document is current

Article History

Received: 24 September 2024

Accepted: 23 December 2024

First Online: 2 January 2025

Declarations

:

: ADNI was approved by the Institutional Review Boards of all participating institutions. All participants provided written informed consent by the Declaration of Helsinki before study enrollment. All study participants, authorized representatives, and study partners have provided written informed consent, and each participating site of ADNI has obtained the necessary ethical permits. More details can be found at adni.loni.usc.edu.ADNI study is conducted in compliance with the protocol, by GCP guidelines, and in full conformity with Regulations for the Protection of Human Subjects of Research codified in 45 CFR Part 46—Protection of Human Subjects, 21 CFR Part 50—Protection of Human Subjects, 21 CFR Part 56—IRBs, and/or the ICH E6, HIPAA, State and Federal regulations and all other applicable local regulatory requirements and laws. Study personnel involved in conducting this study will be qualified by education, training, and experience to perform their respective task(s) by GCP. Informed consent will be obtained by US 21 CFR 50.25, the Tri-Council Policy Statement: Ethical Conduct of Research Involving Humans and the Health Canada and ICH Good Clinical Practice. Applicable HIPAA privacy notifications will be implemented, and HIPAA authorizations signed before protocol procedures are carried out. Information should be given in both oral and written form as deemed appropriate by the site’s IRB.All work complied with ethical regulations for working with human participants. Ethics approval was obtained from the institutional review boards of each institution involved: Oregon Health and Science University; University of Southern California; University of California—San Diego and so on.

: Not applicable.

: The authors declare no competing interests.